Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 3Phase 1 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Dermatologic 1

Conditions

Sarcoma 3Melanoma 2Triple Negative Breast Neoplasms 1Pleural Effusion, Malignant 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1Breast Neoplasms 1

Interventions

Gemcitabine 15pembrolizumab 13Doxorubicin 13Radiotherapy 12Docetaxel 9Nivolumab 8Filgrastim 7Cyclophosphamide 7pazopanib 6Ifosfamide 6130-nm albumin-bound paclitaxel 5Temozolomide 4Irinotecan 4Ipilimumab 4Imatinib Mesylate 4Albumin-Bound Paclitaxel 4talimogene laherparepvec 3surufatinib 3pegfilgrastim 3eribulin 3atezolizumab 3Vinorelbine 3Sirolimus 3Peripheral Blood Stem Cell Transplantation 3PM 01183 3Drug Therapy 3Cisplatin 3toripalimab 2spartalizumab 2selinexor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Sarcoma × talimogene laherparepvec × Clear all
NCT04599062 2026-01-29

TVEC and Preop Radiation for Sarcoma (8 ml Dose)

University of Iowa

Phase 1/2 Active not recruiting
8 enrolled 8 charts
Sarcoma

Sarcoma

NCT02453191 2024-06-20

TVEC and Preop Radiation for Sarcoma (4 ml Dose)

University of Iowa

Phase 1/2 Completed
30 enrolled 12 charts
Sarcoma

Sarcoma

NCT03555032 2021-08-18

TITAN

Royal Marsden NHS Foundation Trust

Phase 1/2 Completed
15 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡